CHICAGO (AP) — CHICAGO (AP) — Xeris Biopharma Holdings, Inc. (XERS) on Tuesday reported a loss of $16.8 million in its first quarter.
On a per-share basis, the Chicago-based company said it had a loss of 12 cents.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.
The company posted revenue of $33.2 million in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $30.8 million.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XERS at https://www.zacks.com/ap/XERS
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.